Advertisement
Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Editor-in-Chief: Alex A. Adjei, MD, PhD, FACP
ISSN: 1556-0864
Online ISSN: 1556-1380
Frequency: 12 issues / year
Ranking: Oncology 54/194
Respiratory System 9/48
Impact Factor: 3.661

Current Issue: June 2013 - Volume 8 - Issue 6

Current Issue Highlights

Actions
View
Actions
View
Login

Quick Poll
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
A 55 year old female patient presents with metastatic atypical bronchial carcinoid tumor (neuroendocrine tumor). She is unresectable and has liver and bone metastases. She does not have carcinoid syndrome or other symptoms of hormone secretion. She is not a candidate for local treatment of the liver or bony metastases at this time. Which of the following treatments options would you employ if you were going to offer her systemic therapy?
 Submit
 Clear
 Results
Foreign Language Editions

JTO is proud to present translations of its content into French and Chinese. We sincerely thank  Jean-Louis Pujol, Wu Yilong, and Tony Mok for their work on the French and Chinese editions.  

French, Selected Articles

French JTO, Vol 1 Issue 1

French JTO, Vol 1 Issue 2

French JTO, Vol 1 Issue 3

 

Chinese, Selected Articles

Chinese JTO, Vol 2 Issue 2

 
Call for Videos
JTO accepts videos as supplemental content to articles. Submission guidelines online.
Advertisement
Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.
Advertisement